About the Authors
- Gustav J. Ullenhag
-
Affiliations Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, Department of Oncology, Uppsala University Hospital, Entrance 78, Uppsala, Sweden
- Fariba Mozaffari
-
Affiliation Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden
- Mats Broberg
-
Affiliation Department of Oncology, Danderyd University Hospital, Stockholm, Sweden
- Håkan Mellstedt
-
Affiliation Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden
- Maria Liljefors
-
* E-mail: maria.gustafsson-liljefors@karolinska.se
Affiliations Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden, Department of Oncology, Karolinska University Hospital Solna, Stockholm, Sweden
Competing Interests
I have read the journal's policy and one author of this manuscript has the following competing interest. Maria Liljefors has declared one compensatory advisory role with Celgene Corporation. This does not alter the authors adherence to PLoS One policies on sharing data and materials. The other authors have declared that no competing interests exist.
Author Contributions
Conceptualization: ML. Formal analysis: ML FM. Funding acquisition: ML HM GU. Investigation: ML GU MB. Methodology: ML. Resources: HM MB. Supervision: HM. Visualization: FM ML GU. Writing – original draft: ML GU. Writing – review & editing: HM ML GU.